To quantify the subcellular localization of MEP50, we scored its staining at the plasma membrane (Figure 6C,D), in the cytosol (Figure 6C,E) and in the nucleus (Figure 6C,F) of the different breast cancer subgroups and in normal breast tissues. Here, WDR77 is linked to breast carcinoma.